Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC [NA]

View source ↗

Summary

This study analyzes the biological characteristics of advanced ALK-rearranged non-small cell lung cancer. It is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Groupe Francais De Pneumo-Cancerologie | Conditions: Non-small Cell Lung Cancer, ALK Gene Rearrangement Positive | NA | Status: RECRUITING